.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advances in the Treatment of Malignant Melanoma

EP. 1: Optimal Management of Locally Advanced Melanoma

June 23rd 2020

EP. 2: Identifying Patients for Neoadjuvant Melanoma Therapy

June 23rd 2020

EP. 3: Molecular Testing in Locally Advanced Melanoma

June 23rd 2020

EP. 4: pCR and Neoadjuvant Therapy for Melanoma

June 23rd 2020

EP. 5: Neoadjuvant Data Explored for Locally Advanced Melanoma

June 23rd 2020

EP. 6: Adjuvant Data Explored for Locally Advanced Melanoma

June 23rd 2020

EP. 7: Adjuvant Therapy for Melanoma: Ongoing Studies of Interest

June 23rd 2020

EP. 8: Adjuvant Therapy for Melanoma: Safety and Efficacy

June 23rd 2020

EP. 9: Systemic Therapy for Metastatic Melanoma

June 23rd 2020

EP. 10: Novel Therapies for Metastatic Melanoma

June 23rd 2020

EP. 11: I/O Dosing Schedules in Metastatic Melanoma

June 23rd 2020

EP. 12: Management of Brain Metastases in Melanoma

June 23rd 2020

EP. 13: Novel Approaches for Relapsed/Refractory Melanoma

June 23rd 2020

EP. 14: Targeted Therapy Versus IO for Relapsed/Refractory Melanoma

June 23rd 2020

EP. 15: Promising Late-Stage Trials in Melanoma

June 23rd 2020

EP. 16: Future Treatment Landscape for Melanoma

June 23rd 2020

EP. 17: Treatment Optimization for Patients With Melanoma

June 23rd 2020